Physician profile
Donald E Roland
NPI 1821074600
$3,284.50
in general payments reported to CMS, 2019-2025
37 companies · $43.26 in 2025
The $43.26 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,182 · 2020: $245 · 2021: $566 · 2022: $892 · 2023: $266 · 2024: $90.23 · 2025: $43.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $566.27 | 2019-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, General - Pain Management |
| Spinal Simplicity, LLC | $477.97 | 2022 | |
| Collegium Pharmaceutical, INC. | $363.49 | 2019-2024 | Xtampza, Belbuca |
| Stimwave Technologies Incorporated | $247.14 | 2019 | |
| Almatica Pharma LLC | $182.83 | 2021-2022 | |
| Abbott Laboratories | $155.51 | 2019-2024 | Proclaim |
| Biodelivery Sciences International, INC. | $126.66 | 2019-2021 | |
| Vertiflex, INC. | $122.99 | 2019 | |
| Amgen INC. | $111.93 | 2019-2021 | |
| Foundation Fusion Solutions, LLC | $104.19 | 2022 | |
| Nevro Corp. | $75.28 | 2019-2021 | |
| Pfizer INC. | $70.88 | 2019-2020 | |
| Assertio Therapeutics, INC. | $56.50 | 2019 | |
| Novartis Pharmaceuticals Corporation | $48.88 | 2019-2020 | |
| Redhill Biopharma INC. | $45.67 | 2020-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $40.52 | 2023 | Lucemyra, Zimhi |
| Kaleo, INC. | $37.94 | 2019 | |
| Scilex Pharmaceuticals INC. | $35.33 | 2019 | |
| Daiichi Sankyo INC. | $34.69 | 2019 | |
| Arbor Pharmaceuticals, INC. | $32.10 | 2019-2020 | |
| Bioventus LLC | $31.39 | 2019-2024 | Supartz Fx Sodium Hyaluronate |
| Lilly USA, LLC | $31.21 | 2019-2021 | |
| Vertos Medical, INC. | $28.43 | 2021 | |
| Allergan, INC. | $27.99 | 2019 | |
| Lundbeck LLC | $25.06 | 2024 | Vyepti |
| Si-Bone, INC. | $24.56 | 2020 | |
| Tersera Therapeutics LLC | $20.82 | 2019 | |
| Avanos Medical | $19.93 | 2022 | |
| Depuy Synthes Sales INC. | $17.84 | 2019 | |
| Abbvie INC. | $16.95 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.35 | 2019 | |
| Nalu Medical, INC. | $16.12 | 2022 | |
| Shionogi INC | $15.67 | 2019 | |
| Medtronic USA, INC. | $15.01 | 2019 | |
| Bard Access Systems, INC. | $14.93 | 2019 | |
| Curonix LLC | $14.63 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pernix Therapeutics Holdings, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Roland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.